Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Marker Therapeutics, Inc. MRKR

Full chart Compare
Set alert

Price alert · MRKR

All alert types
0.89 USD -0.12 (-12.14%)

Nov 5, 2026, 1:44 PM EST

0.88 Day range 1.03
0.84 52-week range 2.46
YTD
-40.44%
1 year
-3.54%

Financial health

Altman Z-Score

-41.27 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E -1.9×
FY 2016: -10.9×FY 2017: -3.4×FY 2018: -0.7×FY 2019: -6.1×FY 2020: -2.4×FY 2021: -1.7×FY 2022: -0.7×FY 2023: -2.8×FY 2024: -2.6×FY 2025: -1.9×
FY 2016 5y median -1.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 202×FY 2018: 514×FY 2019: 616×FY 2020: 146×FY 2021: 58.5×FY 2022: 6.3×FY 2023: 14.6×FY 2024: 4.2×FY 2025: 0.0×
FY 2016 5y median 6.3× FY 2025
P/B 1.4×
FY 2016: 43.2×FY 2017: 10.1×FY 2018: 1.8×FY 2019: 3.0×FY 2020: 2.5×FY 2021: 1.7×FY 2022: 1.1×FY 2023: 3.4×FY 2024: 1.5×FY 2025: 1.4×
FY 2016 5y median 1.5× FY 2025
P/FCF -1.9×
FY 2016: -41.1×FY 2017: -4.4×FY 2018: -7.2×FY 2019: -7.0×FY 2020: -2.3×FY 2021: -2.4×FY 2022: -0.8×FY 2023: -2.9×FY 2024: -2.6×FY 2025: -1.9×
FY 2016 5y median -2.4× FY 2025
EV/EBITDA -0.5×
FY 2016: 43.0×FY 2017: 174×FY 2018: 215×FY 2019: -4.0×FY 2020: -2.1×FY 2021: -1.1×FY 2022: -1.1×FY 2023: -3.0×FY 2024: -0.8×FY 2025: -0.5×
FY 2016 5y median -1.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 174×FY 2018: 215×FY 2019: 412×FY 2020: 127×FY 2021: 34.0×FY 2022: 5.1×FY 2023: 10.1×FY 2024: 1.3×FY 2025: 0.0×
FY 2016 5y median 5.1× FY 2025
FCF Yield -52.7%
FY 2016: -2.4%FY 2017: -22.8%FY 2018: -13.8%FY 2019: -14.2%FY 2020: -42.9%FY 2021: -41.8%FY 2022: -121.5%FY 2023: -33.9%FY 2024: -39.1%FY 2025: -52.7%
FY 2016 5y median -41.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: -2768.4%FY 2018: -60095.0%FY 2019: -5887.4%FY 2020: -3944.9%FY 2021: -154.7%FY 2022: -240.6%FY 2023: -214.6%FY 2024: -104.3%FY 2025: 0.0%
FY 2016 5y median -154.7% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: -6271.0%FY 2018: -71930.3%FY 2019: -10567.3%FY 2020: -6188.3%FY 2021: -3179.3%FY 2022: -563.3%FY 2023: -440.4%FY 2024: -168.7%FY 2025: 0.0%
FY 2016 5y median -440.4% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: -5999.0%FY 2018: -71826.4%FY 2019: -10050.9%FY 2020: -6149.7%FY 2021: -3372.7%FY 2022: -851.9%FY 2023: -248.8%FY 2024: -162.8%FY 2025: 0.0%
FY 2016 5y median -248.8% FY 2025
ROE -72.4%
FY 2016: -39.7%FY 2017: -300.2%FY 2018: -249.3%FY 2019: -48.6%FY 2020: -105.0%FY 2021: -95.2%FY 2022: -152.7%FY 2023: -58.6%FY 2024: -57.8%FY 2025: -72.4%
FY 2016 5y median -72.4% FY 2025
ROIC -76.6%
FY 2016: -137.2%FY 2017: -313.4%FY 2018: -249.3%FY 2019: -50.5%FY 2020: -72.9%FY 2021: -70.7%FY 2022: -72.7%FY 2023: -103.8%FY 2024: -59.9%FY 2025: -76.6%
FY 2016 5y median -72.7% FY 2025
ROA -63.8%
FY 2016: -31.0%FY 2017: -212.0%FY 2018: -238.1%FY 2019: -46.2%FY 2020: -62.9%FY 2021: -61.5%FY 2022: -87.0%FY 2023: -48.1%FY 2024: -48.7%FY 2025: -63.8%
FY 2016 5y median -61.5% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 12.5%FY 2019: 3.5%FY 2020: 118.9%FY 2021: 166.0%FY 2022: 183.0%FY 2023: -5.8%FY 2024: 99.1%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -15.9%
FY 2016: -37.9%FY 2017: -35.2%FY 2018: -1190.7%FY 2019: 84.8%FY 2020: -28.2%FY 2021: -36.7%FY 2022: 49.9%FY 2023: 26.3%FY 2024: 23.7%FY 2025: -15.9%
FY 2016 FY 2025
EPS (diluted) 33.6%
FY 2016: 96.4%FY 2017: -251.1%FY 2018: -567.0%FY 2019: 93.9%FY 2020: -29.8%FY 2021: 10.3%FY 2022: 34.6%FY 2023: 46.1%FY 2024: 38.3%FY 2025: 33.6%
FY 2016 FY 2025
Free Cash Flow -10.1%
FY 2016: -49.9%FY 2017: -29.6%FY 2018: -73.3%FY 2019: -27.6%FY 2020: -57.0%FY 2021: -3.8%FY 2022: 11.3%FY 2023: 39.0%FY 2024: 33.6%FY 2025: -10.1%
FY 2016 FY 2025

Financial Health

Current Ratio 8.4×
FY 2016: 4.6×FY 2017: 3.4×FY 2018: 22.1×FY 2019: 22.8×FY 2020: 3.8×FY 2021: 3.6×FY 2022: 2.1×FY 2023: 5.6×FY 2024: 6.4×FY 2025: 8.4×
FY 2016 5y median 5.6× FY 2025
Quick Ratio 8.4×
FY 2016: 4.6×FY 2017: 3.4×FY 2018: 22.1×FY 2019: 22.8×FY 2020: 3.8×FY 2021: 3.6×FY 2022: 2.1×FY 2023: 5.9×FY 2024: 6.4×FY 2025: 8.4×
FY 2016 5y median 5.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.3×
FY 2016: -1.3×FY 2017: -28.0×FY 2018: -300×FY 2019: 2.0×FY 2020: 0.3×FY 2021: 0.8×FY 2022: 0.3×FY 2023: 1.3×FY 2024: 1.8×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31